Hormonal

Obesity as a treatment indication was associated with a higher likelihood of achieving a 10% or greater weight reduction (AOR, 2.46).

Patients with obesity may experience better weight loss outcomes compared to those with type 2 diabetes.

StrongSupportsmedium confidence

Obesity as a treatment indication vs T2D (AOR, 2.46 [95% CI, 1.83-3.30]).

Hamlet Gasoyan et al. · JAMA Network Open · 2024

Why this rating

Based on a large retrospective cohort study.

Source

One-Year Weight Reduction With Semaglutide or Liraglutide in Clinical Practice

Hamlet Gasoyan et al. · JAMA Network Open · 2024

cohort · n=3389Cited 58×

Read the paper

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →